Dr. Sebasigari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
OU Physicians Building
825 NE 10th Street, Suite 5B
Oklahoma City, OK 73104Phone+1 405-271-3635Fax+1 405-271-5723- Is this information wrong?
Summary
- Dr. Sebasigari is a board certified neurologist specializing in Epilepsy. She completed her residency at Alpert Brown Medical School-Rhodes Island Hopsital in Povidence, RI and completed surgical epilepsy fellowship/neurophysiology fellowship at UT-Houston Medical School, Texas Medical Center ( level 4 epilepsy center). Her areas of interest are women with epilepsy and intractable epilepsy/surgical epilepsy.
Education & Training
- Brown UniversityResidency, Neurology, 2013 - 2016
- Texas College of Osteopathic MedicineClass of 2012
Certifications & Licensure
- TX State License 2016 - 2024
- OK State License 2019 - 2024
- RI State License 2013 - 2016
- OH State License 2012 - 2013
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
Publications & Presentations
PubMed
- 19 citationsBiomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source.Denise Sebasigari, Alexander E Merkler, Yang Guo, Gino Gialdini, Benjamin R Kummer, Morgan Hemendinger, Christopher Song, Antony Chu, Shawna Cutting, Brian Silver, Mit...> ;Journal of Stroke and Cerebrovascular Diseases. 2017 Jun 1
- 65 citationsMDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma.Yoko Tabe, Denise Sebasigari, Linhua Jin, Martina Rudelius, Theresa Davies-Hill, Kazunori Miyake, Takashi Miida, Stefania Pittaluga, Mark Raffeld> ;Clinical Cancer Research. 2009 Feb 1
- 34 citationsExpression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.Antonio Martinez, Stefania Pittaluga, Martina Rudelius, Theresa Davies-Hill, Denise Sebasigari, Thomas J. Fountaine, Stephen M. Hewitt, Elaine S. Jaffe, Mark Raffeld> ;The American Journal of Surgical Pathology. 2008 Aug 1
Press Mentions
- What It’s like to Treat Asylum Seekers and Refugees in the US, OverseasOctober 28th, 2023
Hospital Affiliations
- OU HealthOklahoma City, Oklahoma
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: